Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

NCT04035226

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Oncology Institute of Hope and Innovation Glendale, California, United States
  • Marin Cancer Center Greenbrae, California, United States
  • Asclepes Research Weeki Wachee, Florida, United States
  • Oncology Hematology Assoc of Central Illinois, P.C. d.b.a. Illinois CancerCare, P.C. Peoria, Illinois, United States
View all 75 locations
View Trial Details
Completed

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

NCT02555839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • LKH Feldkirch, Intern E, Hämatologie Feldkirch, Austria
  • Medical University Graz Graz, Austria
  • KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Linz, Austria
  • Kepleruniversitätsklinikum GmbH, Hämatologie und Internistische Onkologie Linz, Austria
View all 13 locations
View Trial Details
Completed

Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)

NCT03748953

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Beijing Chaoyang Hospital Capital Medical University Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Completed

REST - Replacing Steroids in the Transplant Ineligble

NCT04939844

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Zealand University Hospital Roskilde, Denmark
  • Oslo University Hospital Oslo, Norway
  • Helse Stavanger HF Stavanger, Norway
  • St. Olav University Hospital Trondheim, Norway
View Trial Details

Related conditions